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Background: Targeted recruitment of chromatin-modifying enzymes to clusters 
of CpG dinucleotides contributes toward the formation of accessible chromatin. By 
interprimate comparison we previously identified the set of nonpolymorphic human-
specific CpGs (CpG ‘beacons’) and revealed that these loci were enriched for human 
disease traits. Due to their human-specific CpG density change, extreme CpG ‘beacon’ 
clusters (≥20 CpG beacons/kb) were predicted to identify permissive chromatin peaks 
within the human genome. Aim: We set out to explore these sequence-defined regions 
for evidence of an active chromatin signature. Results: Using available comparative 
primate epigenomic data from neurons of the prefrontal cortex, we show that these 
CpG ‘beacon’ clusters are indeed enriched for being human-specific H3K4me3 peaks 
(χ2: p < 2.2 × 10-16) and thus predictive of permissive chromatin states. These sequence 
regions had a higher predictive value than previous selective analyses. We also show 
that both human-specific H3K4me3 and CpG ‘beacon’ clusters are increased within 
current and ancestral telomeric regions, supporting an association with recombination, 
which is higher towards the distal ends of chromosomes. Conclusion: Therefore, CpG-
focused comparative sequence analysis can precisely pinpoint chromatin structures 
that contribute to the human-specific phenotype and further supports an integrated 
approach in genomic and epigenomic studies.
Keywords:  chromatin • comparative epigenomics • CpG islands • DNA methylation 
• epigenetics • epigenomics • gene regulation • human evolution • primate epigenetics
Background
Clusters of CpG dinucleotides, termed CpG 
islands (CpGis), act as a genomic platform 
for gene expression by providing an accessible 
environment for the binding of the basal tran-
scription machinery [1,2]. They facilitate this 
setting, due to both their distinctive density 
and predominately unmethylated state, by 
recruiting specific factors that modify the three 
dimensional structure of the local chromatin 
[3,4]. Hence these islands reside within an 
expanse of repressed genome, forming active or 
transcriptionally competent promoters [5] and 
possess the characteristic permissive H3K4me3 
histone signature [6]. This chromatin configu-
ration is itself associated with expression, but 
also may further enable the recruitment of 
components required for this activity [7,8].
Due to this direct effect on 3D chromatin 
structure by CpG dinucleotides [5], and the 
potential for regulatory modulation it creates, 
we previously examined the primate-align-
able portion of human genome for nucleotide 
sequence change that has led to the forma-
tion or maintenance of human-specific CpGs 
[9]. This was performed by sequence compar-
ison of six primates (Enredo-Pecan-Ortheus 
[EPO] alignment including: human, chim-
panzee, gorilla, orangutan, rhesus macaque 
and marmoset [10,11]). The resultant nonpoly-
morphic human-specific CpGs were termed 
human CpG ‘beacons’ and identify prospec-
tive novel human-specific regulatory regions. 
These CpG ‘beacons’ are now shown to be 
markedly enriched in the dynamic portion 
of the human DNA methylome [12]. We then 
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identified 21 regions of extreme CpG ‘beacon’ clusters 
(empirical p < 1 × 10-3) within the human genome. 
These were shown to colocate with four causative 
genes in monogenic mental/developmental disorders 
(ANKRD11 [13], CHL1 [14], EHMT1 [15] and VLDLR 
[16,17]), and genes implicated with complex traits such 
as autism and psychiatric disease (ANKRD11 [18], 
DLGAP2 [19] and DPP10 [18,20]), as well as reidenti-
fying the noncoding RNA, HAR1A [21], implicated 
in cortex development, by precisely hitting its CpGi. 
These loci were significantly statistically enriched 
for neurological trait-related genes. As methylation is 
inversely correlated with CpGi density [22,23], we were 
also able to indicate the functional consequences of 
species-specific CpG density change, through compar-
ative DNA methylome analysis in human, chimpanzee 
and macaque, with expected changes in methylation in 
orthologous CpGi.
A recently published comparative chromatin analy-
sis for human-specific H3K4me3 within the prefron-
tal cortex (PFC) between human, chimpanzee and 
macaque identified 410 loci with a human-specific 
peak gain [24]. This dataset provided the ideal opportu-
nity to test whether the hypothesized structural effect 
of CpG ‘beacon’ clusters did in fact lead to human-
specific chromatin modification. Furthermore, these 
data are derived from a cortical region fundamental in 
human-derived higher functioning [25,26].
Therefore, we tested this hypothesis and identified 
that CpG ‘beacon’ clusters are indeed enriched for 
these human-specific accessible chromatin regions. 
Furthermore they are increasingly likely to precisely 
locate the most significant fraction of these peaks. 
This supports the idea that human species-specific 
CpG ‘beacons’ have played a critical role in human 
evolution, as they locate significant regions of human-
specific functional epigenomic change in the genome, 
and that CpG-focused comparative sequence analy-
sis between the closely related primate family can be 
highly informative.
Methods
Data
Human-specific H3K4me3 PFC peak locations were 
taken from the supplementary data (Supplementary 
Table S3) of Shulha et al. [24].
Location of human Chip-seq H3K4me3 PFC 
peaks were accessed from Maunakea et al. [27], via the 
UCSC Genome Browser Table Browser: Regulation; 
UCSF Brain DNA Methylation; ucsfChipSeqH3K-
4me3BrainCoverage. The sequencing reads are avail-
able through the NCBI SRA (study accession number 
SRP002318) [28]. The CpG ‘beacon’ data is browser 
viewable within UCSC [29].
Analysis
All statistical calculations and simulations were per-
formed in R [30]. Wilcoxon test was used for hs-
H3K4me3 and CpG ‘beacon’ comparison between 
loci with 0 CpG ‘beacons’ and those with ≥20, using 
the FDR p-values calculated by Shulha et al. for 
human versus chimpanzee and macaque regions [24]. 
For this FDR comparison analysis, those loci with an 
FDR p = 0 were capped at a p = 1 × 10-200. Genome 
intersect comparisons were via the BEDTools package 
command intersectBed [31]. Genomic representation 
plot was constructed with Circos [32]. Genomic enrich-
ment calculations performed with GREAT, by the 
region-based binominal method, with regional default 
for associated genomic regions, but with extension 
reduced to 100 kb [33]. A locus was considered to reside 
in a distal, or telomeric region, if it overlapped the first 
or last chromosome band (coordinates via Ensembl 
Biomart). All human genomic coordinates given are in 
the GRCh37/hg19 build.
Results
Primate comparative sequence analysis predicts 
human-specific chromatin state
A set of 410 human-specific peaks of the activating 
chromatin modification, H3K4me3, were identified 
from a total of 34,639 human peaks, by a compara-
tive analysis of the PFC of human, chimpanzee and 
macaque by Shulha et al. [24]. Within the 21 extreme 
CpG ‘beacon’ peak regions we previously identified [9], 
available data from Maunakea et al. had shown that 8 
possessed H3K4me3 PFC peaks [9,27]. Comparison of 
these 8 peaks with the Shulha et al. dataset revealed 
5 to be identified as human-specific H3K4me3 (hs-
H3K4me3) peaks. Therefore the H3K4me3 signal 
in these CpG ‘beacon’ clusters is strongly enriched 
for being present only in human and not in chim-
panzee or macaque (χ2: p < 2.2 × 10-16). These five 
hs-H3K4me3 peaks were precisely located by extreme 
CpG ‘beacon’ clusters (≥20 CpG ‘beacons’/kb) within 
or near the genes; ANKRD11, CHL1, DPP10, HAR1A 
and PSD4 (see Figures 1 & 2 & Supplementary Figure 1; 
accessible online at www.futuremedicine.com/doi/
suppl/10.2217/epi.13.74).
Randomization via ShuffleBed [31] and genome 
structure correction (GSC) enrichment [34,35] were 
highly significant (both p < 1 × 10-5). However, both 
the extreme CpG ‘beacon’ clusters and H3K4me3 
peaks are not likely to be found with equal chance 
throughout the entire genome, but are highly likely 
to reside within CpG-dense regions. To account for 
this, we permutated the 21 loci, representing random 
extreme CpG clusters, only from the total of 18,665 
human PFC H3K4me3 peaks, out of the total of 
future science group
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37,902 (identified from Maunakea et al. [27], as the 
total set genome co-ordinates are not available from 
Shulha et al. [24]) that overlap CpG-dense regions 
(22,374 Ensembl CpGis). With 10,000 permutations 
this did not exceed the observed five peaks (average: 
0.466 ± 0.677 overlapping peaks per genome simula-
tion, empirical p < 1 × 10-5). Therefore while as much 
as ∼83.4% of brain PFC CpGi’s possess the H3K4me3 
signature, only ∼1.8% have human-specific H3K4me3, 
whereas by contrast, the CpG ‘beacon’ clusters are 
statistically strongly enriched with ∼23.8% having 
human-specific H3K4me3 (five out of 21 clusters).
Further statistical overlap at lower CpG cluster 
thresholds
CpG ‘beacon’ H3K4me3 overlaps were not only 
restricted to the most extreme clusters (≥20 CpG 
‘beacons’/kb) but also found at lower levels. At a CpG 
‘beacons’ density level of 15/kb, 11 out of a total of 63 
cluster regions overlap with hs-H3K4me3 (simulation 
average: 1.387 ± 1.164) and 20 out of a total of 254 
cluster regions overlaps at CpG ‘beacons’ density level 
of 10/kb (simulation average: 5.604 ± 2.347). Permu-
tation analysis therefore for both of these results are 
highly statistically unlikely (all empirical p < 1 × 10-5).
When we initially calculated the set of the extreme 
CpG ‘beacon’ clusters we took a conservative genome-
wide empirical cut-off of p < 1 × 10-3, which was 
reached at a density level of 20/kb CpG ‘beacons’. The 
permutation however does not become nonsignificant 
(p > 0.05) until a density level of <17/kb (p = 0.210) 
and furthermore even at the 17/kb level the binominal 
genomic enrichment results via GREAT [33] for cogni-
tion is significant (p = 7.6 × 10-6, FDR Q = 3.36 × 10-2). 
The H3K4me3 peak overlap at 17/kb is 7, out of a pos-
sible 36, (empirical p < 1 × 10-5, see Table 1). While the 
lower CpG ‘beacon’ density levels of 15/kb and 10/kb 
are not statistical outliers in their own right, this still 
does not negate their potential functional importance, 
and the enrichment for hs-H3K4me3 in these loci 
strongly supports this.
Additionally, the defined CpG ‘beacons’ were iden-
tified only within the ∼80% of the human genome 
with rigorous primate homology from the EPO 
sequence block alignments [10,11] that included, at 
least, human, chimpanzee and one other primate 
sequence (abbreviated as the ‘h1c1o1’ genome). Of 
the total 410 hs-H3K4me3 peak regions, only 257 
lie within this majority of the genome, therefore, an 
under-representation (∼20% loss genome but 34.15% 
reduction in peaks; χ2: p < 2.2 × 10-16). Thus the pri-
mate nonhomologous regions contain more identi-
fied hs-H3K4me3 peaks. This may be due to stronger 
genetic divergence within these regions having a con-
future science group
Human-specific CpG ‘beacons’ identify human-specific prefrontal cortex H3K4me3 chromatin peaks    Research Article
Fi
g
u
re
 1
.  
U
C
SC
 b
ro
w
se
r 
d
is
p
la
y 
sh
o
w
in
g
 t
h
e 
co
lo
ca
ti
o
n
 o
f 
o
ve
rl
ap
p
in
g
 h
u
m
an
-s
p
ec
ifi
c 
H
3K
4
m
e3
 p
ea
k 
(t
o
p
 le
ve
l m
au
ve
) 
an
d
 e
x
tr
em
e 
C
p
G
 ‘b
ea
co
n
’ c
lu
st
er
s 
(r
ed
) 
at
 t
h
e 
5´
 C
H
L1
 lo
cu
s.
 A
ll 
fi
g
u
re
s 
ar
e 
vi
ew
ab
le
 in
 c
o
lo
r 
o
n
lin
e 
at
 w
w
w
.f
u
tu
re
m
ed
ic
in
e.
co
m
/d
o
i/
fu
ll
/1
0.
22
17
/e
p
i.1
3.
74
.
S
ca
le
ch
r3 21 0
H
um
an
_C
pG
_B
ea
co
ns
H
um
an
_C
pG
_B
ea
co
ns
C
pG
: 1
71
C
pG
s
12
H
3K
4m
e3
 r
aw
 s
ig
na
l
1
H
um
an
-s
pe
ci
fic
H
3K
4m
e3
G
M
12
87
8 
C
hr
om
H
M
M
C
hr
om
at
in
 s
ta
te
 s
eg
m
en
ta
tio
n 
by
 H
M
M
 fr
om
 E
N
C
O
D
E
/B
ro
ad
H
3K
4m
e3
 C
hI
P
-S
eq
 R
aw
 S
ig
na
l
C
H
L1
C
H
L1
C
H
L1
C
H
L1
C
pG
 is
la
nd
s 
(is
la
nd
s 
<
30
0 
ba
se
s 
ar
e 
lig
ht
 g
re
en
)
C
pG
s
H
um
an
_C
pG
_B
ea
co
ns
H
um
an
-s
pe
ci
fic
 H
3K
4m
e3
5 
kb
hg
19
24
3,
50
0
24
3,
00
0
24
2,
50
0
24
2,
00
0
24
1,
50
0
24
1,
00
0
24
0,
50
0
24
0,
00
0
23
9,
50
0
23
9,
00
0
23
8,
50
0
23
8,
00
0
23
7,
50
0
23
7,
00
0
23
6,
50
0
23
6,
00
0
23
5,
50
0
23
5,
00
0
U
C
S
C
 g
en
es
 (
R
ef
S
eq
, U
ni
P
ro
t, 
C
C
D
S
, R
 fa
m
, t
R
N
A
s 
an
d 
co
m
pa
ra
tiv
e 
ge
no
m
ic
s)
K
56
2 
C
hr
om
H
M
M
H
1-
hE
S
C
 C
hr
om
H
M
M
H
ep
G
2 
C
hr
om
H
M
M
H
M
E
C
 C
hr
om
H
M
M
H
U
V
E
C
 C
hr
om
H
M
M
H
S
M
M
 C
hr
om
H
M
M
N
H
LF
 C
hr
om
H
M
M
N
H
E
K
 C
hr
om
H
M
M
H
um
an
_C
pG
_B
ea
co
ns
_p
ea
k_
>
5
24 Epigenomics (2014) 6(1)
sequential stronger influence on the epigenome, but 
also could be contributed to by a higher potential ana-
lytical bias component. 30 (∼12%) of these 257 peaks 
overlap with a CpG beacon peak of at least ≥5/kb.
Predicted H3K4me3 peaks have the strongest 
evidence for a human-specific state
By utilizing the FDR p-value calculated by Shulha 
et al. for their H3K4me3 peaks [24], we find that the 
most extreme CpG ‘beacon’ clusters that overlap with 
hs-H3K4me3 peaks have a significantly higher likeli-
hood of being truly human-specific peaks. These loci 
have more significant FDR p-values in comparison 
with both potential chimpanzee and macaque loci (loci 
with CpG ‘beacons’ = 0, compared with those with 
≥20, Wilcoxon p = 3.57 × 10-3 for human vs chim-
panzee and p = 2.50 × 10-2 for human vs macaque, see 
Figure 3A & B). Consequently, while the 410 peaks have 
variable certainty as to being truly human-specific, as 
represented by these FDR values, the most likely hs-
H3K4me3 lie within extreme CpG clusters. Therefore 
the conservatively calculated enrichment within these 
hs-H3K4me3 would be even stronger if false-positive 
hs-H3K4me3 peaks were excluded. Additional data-
sets from the other closely related primates, includ-
ing orangutan and gorilla, would aid the reduction in 
future science group
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Figure 2. Human chromosomes 2, 3, 16 and 20. Outer ring: chromosomes with banding patterns. Dense edge 
ring: Enredo-Pecan-Ortheus [10,11] h1c1o1 coverage of these chromosomes. Blue peaks: extreme CpG ‘beacon’ 
peak locations. Human-specific H3K4me3 location with false discovery rate log p-values compared to chimpanzee 
(orange), macaque (green) and overlapping chimpanzee and macaque (olive). Location of ANKRD11, CHL1, DPP10, 
HAR1A and PSD4 indicated with colocating CpG ‘beacon’ clusters and human-specific H3K4me3. The highlighted 
yellow wedge is the location of the chromosome 2qFus (2q13–2q14.1) with enrichment of both extreme CpG 
‘beacon’ clusters and of human-specific H3K4me3 peaks (χ2: p = 1.045 × 10-5).
www.futuremedicine.com 25
false-positive human-specific peaks, however these are 
currently not publicly available.
Double peaks & telomeric bias
Peaks of hs-H3K4me3 were also identified by Shulha 
et al. to occur in pairs or groups within 0.5–1 Mb, 
with an approximately two- to three-fold enrichment. 
Recent ENCODE data has identified an average peak 
region of long range interaction of promoters, enhanc-
ers and CTCF to be approximately 120 kb upstream 
of the TSS [36]. This grouping propensity is also seen 
within the CpG ‘beacon’ overlap peaks (i.e., DPP10 
future science group
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Table 1. Human-specific CpG ‘beacon’ clusters with human-specific H3K4me3.
CpG 
‘beacons’/ 
1 kb
Locus Gene Location Distance 
to TSS
FDR human-
specific 
vChimpanzee
FDR human-
specific 
vMacaque
Supporting 
PFC 
H3K4me3† 
#OMIM
32 chr20:61732970-
61734710
HAR1B 5´ promoter 0 5.302 × 10-10 0.00 × 10+00 Yes *610556/ 
*610557
26 chr2:113914422-
113915745
PSD4 Upstream 15,814 4.101 × 10-9 4.670 × 10-11 Yes *614442
22 chr2:115419442-
115420562
DPP10 / 
LOC389023
Intragenic 200,263 1.340 × 10-38 0.00 × 10+00 Yes *608209
21 chr3:237734-
240480
CHL1 5´ promoter 0 2.296 × 10-42 3.501 × 10-92 Yes *607416/ 
#613792
21 chr16:89322850-
89324461
ANKRD11/ 
ZNF778
3´ 38,740 1.239 × 10-27 0.00 × 10+00 Yes *611192/ 
#148050
17 chr15:101,457,966-
101,461,331
LRRK1 5´ promoter 0 4.105 × 10-9 3.824 × 10-47 Yes *610986
17 chr3:2139259-
2142710
CNTN4 5´ promoter 0 2.494 × 10-25 1.156 × 10-37 Yes *607280/ 
#613792
17 chr2:115918003-
115921686
DPP10 5´ promoter 0 7.824 × 10-29 1.046 × 10-13 Yes *608209
Human-specific CpG ‘beacon’ clusters ≥17/kb (empirical p < 0.05) with supporting human-specific H3K4me3 from Shulha et al. [24]. 
†Supporting human PFC H3K4me3 signature from the Maunakea et al. data [27]. 
FDR: False discovery rate; OMIM: Online Mendelian Inheritance in Man; PFC: Prefrontal cortex; TSS: Transcription start site.
Figure 3. Stronger human-specific H3K4m3 peaks identified (FDR p-value) with CpG ‘beacon’ density in both human versus 
chimpanzee (A), and versus rhesus macaque (B) (Wilcoxon test CpG ‘beacon’ 0 vs ≥20, p = 3.57 × 10-3 chimpanzee and p = 2.50 × 10-2 
macaque [p = 0 values capped at 10-200]). This analysis is within the primate-alignable (EPO [10,11]) portion of the human genome. 
EPO: Enredo-Pecan-Ortheus; FDR: False discovery rate.
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and EXOC2, among others; Supplementary Table 1). 
These double peaks had an average genomic distance 
between them of ∼126 kb. Shulha et al. showed evi-
dence of these close double peak regions having physi-
cal interaction by ChIA-PET. ChromHMM segmenta-
tion analysis [37] found that colocating with H3K4me1, 
a high level of H3K4me3 (61–80%) was also in Strong 
Enhancer Type 4, thus potentially implicating some of 
these regions in this role.
We previously identified a distal chromosome or 
telomeric bias in CpG ‘beacon’ clusters (CpG ‘beacon’ 
cluster 20/kb = 52.3% in terminal chromosome bands 
[9]), due to the role recombination-associated biased 
gene conversion (BGC) plays in their formation. This 
being the biochemical bias in the DNA repair mecha-
nism that occurs in heteroduplexed DNA, formed dur-
ing crossing over, leading to clustered weak-to-strong 
‘biased’ substitutions (AT to GC) [38,39]. Therefore, we 
assessed whether hs-H3K4me3 also have a telomeric 
bias which could be contributing to these peak group-
ings. We calculated there is in fact a >twofold enrich-
ment within these telomeric regions compared to all 
human H3K4me3 peaks (χ2: p < 2.2 × 10-16).
We also previously identified a strong clustering 
bias of CpG ‘beacon’ clusters, within the historic chro-
mosome 2qFus region, due to past recombination in 
these archaic telomeric regions [40]. Examining the hs-
H3K4me3 peaks, these also show an enrichment for 
this 2qfus region (2q13–2q14.1 – chr2: 110,200,001–
118,800,000) with an average 0.699 peaks/Mb com-
pared with ∼0.131 peaks/Mb across the genome and an 
approximately sixfold enrichment over the expected hs-
H3K4me3 compared to all the human H3K4me3 peaks 
present here (χ2: p = 1.045 × 10-5; see Figure 2). Hence 
this further supports the model of recombination-asso-
ciated BGC increase in CpGs leading to the formation 
of H3K4me3 peaks. Cohen et al. also recently proposed 
BGC islands, as one of the categories of CpG islands, 
due to their formation by this process [41].
CpG ‘beacons’ predict human-specific 
H3K4me3 peaks greater than other 
comparative sequence change
Shulha et al. compared the identified hs-H3K4me3 
peaks with known regions of accelerated human-
specific sequence change, such as the human accel-
erated regions (HARs) [21] and found only minimal 
overlap (1/49 loci = HAR1A), as well as nine further 
studies of positive selection collated together by Akey 
[42], which also showed low intersection. Due to this 
inadequate overlap they concluded that comparative 
sequence analysis was poorly informative of potential 
functional epigenomic differences [24] and thus that 
important changes in chromatin structure and func-
tion cannot be identified by comparative genomic 
analysis alone. Furthermore, we also compared the 
hs-H3K4me3 regions with the human accelerated 
conserved noncoding (HACNS – 0/992 loci) [43] and 
accelerated noncoding (ANC – 6/1356 loci) [44] sets 
and these also show minimal colocation. However, as 
shown, the specific CpG dinucleotide change, indi-
cated by CpG ‘beacons’ through six primate compari-
son, enabled a far better prediction of hs-H3K4me3 
than any of these methods. Therefore important 
changes in chromatin structure and epigenomic func-
tion can be identified by specific comparative genomic 
analysis.
We simulated these data by permutation with ran-
dom selections sets of one to 1000 loci from the total 
of 18,665 human peaks (1000 × randomization each) 
that then overlap the 410 hs-H3K3me3 and plotted 
these results on a scatter plot also with the observed 
overlaps for all these mentioned studies (blue squares) 
and the CpG ‘beacon’ data (red and green Squares) 
(see Figure 4). This clearly shows that while the selec-
tion studies perform either the same or worse than the 
simulation values, the CpG ‘beacon’ clusters overlap 
is far in excess of the maximum simulation results (all 
empirical p < 1 × 10-5), with those adjusted for the 
reduced numbers within the primate EPO alignment 
performing the best (green squares).
The only study that approaches the success of the 
CpG ‘beacons’ is the expanded set of 202 HARs 
(∼85.6 kB), as while the top 49 HARs perform poorly, 
when this set is extended further these loci begin to 
capture more CpG ‘beacon’ clusters, such that ∼85.7% 
of the hs-H3K4me3-overlapping HAR_202 regions 
are CpG ‘beacon’ clusters of ≥10/kb (12 out of 14). 
This overlap, as discussed previously, indicates the 
strong role of BGC in the formation of both CpG 
‘beacon’ clusters and regions of extreme species-spe-
cific dinucleotide divergence in the human genome, 
driven by recombination [9,38]. Thus, further indicat-
ing how this process, with a by-product of modulat-
ing sequence, can affect genomic 3D structure in these 
extreme locations.
The simulation also clearly displays why the 
comparison against the 9 positive selective stud-
ies as used by Shulha et al. [24] is inappropriate to 
identify human-specific change, as these studies use 
human population variation and linkage disequilib-
rium data that is too recent to identify significant 
genetic changes that have led to variation between 
primates. Furthermore, the other comparative stud-
ies lose power in comparison with the ‘beacon’ analy-
sis, as they regard all nucleotide change as equal, are 
focused wider than an interprimate analysis, and in 
those that center exclusively on nontranscript over-
future science group
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lapping sequence, such as the ANC regions [44], may 
exclude many promoter hs-H3K4me3 regions that 
reside 5´ within first exons, or intragenic promoter 
CpGi loci. The inaccuracy of using human popu-
lation data can be starkly seen by the fact that the 
genome space associated with two or more selective 
studies from Akey is 244.7 Mb, compared with only 
29.9 kb for the extreme CpG ‘beacon’ ≥20/kb peaks 
regions, or ∼0.01% of this, and yet the latter has 
23.8% successful overlap with hs-H3K4me3 peaks 
versus 2.36% of the former.
Discussion
DNA methylation is essential for mammalian develop-
ment and is almost exclusively restricted to the CpG 
dinucleotide in differentiated cells [45]. Therefore, this 
epigenomic mechanism requires the presence of the 
CpG genetic sequence template in order to facilitate 
the modification’s dynamic functionality. Although 
a lower level of non-CpG cytosine methylation has 
been identified to occur in the human brain, predomi-
nately at CACC motifs [46]. We previously identified, 
by interprimate comparative analysis, human-specific 
CpG ‘beacon’ clusters and found these to be enriched 
for human disease and phenotype loci. The facilitated 
epigenetic role that these clusters of CpGs provide is 
not restricted to DNA methylation, but may also be 
involved in enabling other modifications of DNA, 
including hydroxymethylation [47]. Furthermore, we 
predicted that these clusters would influence chroma-
tin structure, due to their significant human-specific 
change in CpG density. Using the PFC hs-H3K4me3 
data from Shulha et al. [24] we have shown strong evi-
dence of this. This sequence relationship is only asso-
ciated with H3K4me3, and presently only tested in 
PFC, but further analysis, when other comparative 
epigenomic tissue signatures become available, may be 
revealing.
Mechanisms have evolved to reduce the local func-
tional impact of transposable elements, such as Alu ele-
ments [48], which while possessing high CpG content, 
are usually methylated [49]. However sequence diver-
gence of homologous loci through highly dissimilar 
species-specific recombination [50], driven by the rap-
idly evolving recognition motif of PRDM9 [51,52], can 
lead to BGC-associated increase in local GC content 
[53]. This can concurrently increase CpG dinucleotides 
and form increasingly dense [54] or new CpGi, within 
these hotspots [55], even without requiring the force 
of positive selection [41]. These CpGi regions, recruit 
chromatin-modifying enzymes, such as Cfp1, as has 
been experimentally shown by CpG island inclusion 
experiments in a mouse model by Thomson et al. [3]. 
This, in turn, leads to the targeted formation of acces-
sible H3K4me3 chromatin structure in the appropriate 
genomic regions [56]. This chromatin signature may 
not itself be causative in expression, but is indicative 
of a permissive promoter formation. Furthermore inde-
pendent of transcription status, both CpG content and 
CpGi width correlate with local nucleosome deple-
tion [57].
Dreszer et al. has previously identified outlying 
regions of high BGC with loci of extreme sequence 
diverge, and these regions also have a telomeric or dis-
tal bias, due to the higher level of recombination that 
occurs there [38,58]. CpG ‘beacon’ clusters also share 
these properties [9] and thus link recombination with 
H3K4me3 formation (see Hypothesis in Figure 5). 
Therefore the extreme CpG increase identified in 
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Figure 4. Comparison of studies: proportion of identified loci with 
overlapping human-specific H3K4me3. CpG ‘beacon’ clusters identify 
hs-H3K4me3 peaks more successfully than extreme human nucleotide 
change or studies of selection. Scatter plot of permutated data for 
random selection of sets of one to 1000 loci from the total of 18,665 
human peaks (1000× randomization each) that then overlap the 410 
hs-H3K3me4 loci. Upper line: Loess regression line of maximum simulation 
value; golden points: average for each random selection with average 
Loess regression line overlaid in grey; red squares: CpG ‘beacon’ clusters; 
green squares: CpG ‘beacon’ clusters adjusted for the fact that the 
primate EPO alignment only contains 257 hs-H3K4me3 peaks; blue 
squares: selective studies – HACNS (HACNS – 0/992) [43] and ANC (ANC – 
6/1356) [44], Select_x2, _x3 and _x4+ are overlaps with studies combined 
by Akey [42] with loci colocating in 2, 3 or 4 or more studies. HARs are 
the 49 top HARs [21]. HAR_202 is an expanded set of 202 HARs, with this 
set the only nonbeacon analysis to perform well, as this larger grouping 
has a strong overlap with CpG ‘beacons’ (∼85.7% of the hs-H3K4me3 
overlapping CpG ‘beacons’ ≥10/kb). 
ANC: Accelerated noncoding; CB_10: CpG ‘beacon’ clusters ≥10/kb; 
CB_15: CpG ‘beacon’ clusters ≥15/kb; CB_20: CpG ‘beacon’ clusters ≥20/kb; 
HAR: Human accelerated regions; HACNS: Human accelerated conserved 
noncoding; hs-H3K4me3: Human-specific H3K4me3.
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human, within these loci, is not due to severe concur-
rent loss of CpGs in all of the other primates. Thus 
we have shown by our primate-specific comparison 
that these sequence-directed or associated epigenetic 
changes, identified in murine models, in fact occur in 
human, and furthermore within the significant brain 
tissue of the human PFC.
Comparing DNA sequence can identify human-
specific epigenomic variation that can increase the 
understanding of brain function unique to humans. 
Epigenetics complements genetics, and is not in con-
flict with it, justifying an integrated approach in 
genomic and epigenomic analyses for disease studies 
[59–61]. Structural effects on the genome through chro-
matin modification can in fact be deduced by direct 
sequence comparison, especially when the importance 
of species–specific CpGs ‘beacons’ in the formation 
of H3K4me3 is acknowledged and the additional 
power of comparison between multiple closely-related 
primates is employed.
Conclusion
We have shown that CpG ‘beacon’ clusters can pre-
cisely locate hs-H3K4me3 and, furthermore, are more 
enriched in the strongest human-specific peaks. This 
supports our work that the most extreme CpG ‘bea-
con’ peaks map to tissue-invariant peaks of accessible 
H3K4me3 chromatin, specific only to the human 
genome, and implicated in the formation of the human 
phenotype [9].
Future perspective
The integration of genomic, epigenomic and transcrip-
tomic sequence data will enable an increasingly com-
prehensive understanding of biology. Rapid advances 
in sequencing technology will speed this powerful 
combinatorial analysis and facilitate detailed explo-
ration of the evolution of malignant, population and 
species–specific variation. Increased understanding 
of how genetic sequence change, such as in CpGs 
and transcription factor motifs, may be associated 
with active or passive epigenomic alterations will aid 
deciphering these data. Furthermore, through these 
methods, the identification of functional differences, 
between humans and other closely related primates, 
will help explain the human-specific phenotype and 
increase the understanding of human pathophysiology.
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Figure 5. The hypothesis associating potential recombination-driven 
permissive chromatin formation with CPGi formation via CpG ‘beacons’. 
The histone methylase PRDM9 directs recombination via motif-specificity, 
with resultant biased gene conversion within these regions increasing GC 
content and therefore CpG numbers. Dense CpG regions are able to recruit 
chromatin-modifying factors such as Cpf1, which lead to the formation of 
permissive H3K4me3 chromatin domains. Due to the strong association 
of PRDM9 with recombination [51], ancestral alleles of this rapidly 
evolving DNA-binding factor [52] are hypothesized to be implicated in this 
recombination-associated biased gene conversion [39].
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